Viewing Study NCT02057133


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2026-02-28 @ 4:02 PM
Study NCT ID: NCT02057133
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-20
First Post: 2014-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module